TEVA PHARMACEUTICALS USA, INC.;TEVA PHARMACEUTICAL INDUSTRIES LTD.;ULANENKO, Konstantin;LAXER, Avital
发明人:
LAXER, Avital,ULANENKO, Konstantin
申请号：
USUS2013/039911
公开号：
WO2013/169746A2
申请日:
2013.05.07
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The subject invention provides pharmaceutical compositions Containing laquinimod or a pharmaceutically acceptable salt thereof, an isolated compound of N-ethyl-4-hydroxyl-1 -methyl-5- (methyl (2, 3,4,5, 6-pentahydroxyhexyl ) amino) -2-oxo-N-phenyl-1, 2- dihydroquinoline- 3 -carboxamide or a salt thereof, compositions containing N-ethyl-4-hydroxyl-1-methyl-5- (methyl (2,3,4,5,6- pentahydroxyhexyl ) amino) -2-oxo-N-phenyl-1, 2-dihydroquinoline-3- carboxamide and methods of preparing the same.L'invention concerne des compositions pharmaceutiques contenant du laquinimod ou un sel pharmaceutiquement acceptable de celui-ci, un composé isolé de N-éthyl-4-hydroxyl-1-méthyl-5-(méthyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phényl-1,2-dihydroquinoléine-3-carboxamide ou un sel de celui-ci, des compositions contenant le N-éthyl-4-hydroxyl-1-méthyl-5-(méthyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phényl-1,2-dihydroquinoléine-3-carboxamide et leurs procédés de préparation.
